Analysts at William Blair say dapiglutide’s 11.6% weight reduction at 28 weeks could still be better, given that Zealand’s ...

Harliku is the only FDA-approved drug for alkaptonuria, a rare condition characterized by skin discoloration, arthritis and ...

California’s life sciences jobs led the nation last year, according to a new California Life Sciences (CLS) report. However, ...

Exemptions to new export control policies have allowed companies to ship patients’ biological materials to foreign ...

Looking for a biopharma job in San Diego? Check out the BioSpace list of eight companies hiring life sciences professionals like you.

“This is a historic day in the decades-long fight against HIV,” Gilead CEO Daniel O’Day said in the company’s announcement.

In this episode of Denatured, BioSpace's Head of Insights Lori Ellis discusses key themes from BIO and DIA, including the funding environment, with Rich Daly, CEO of Catalyst Pharmaceuticals, Peter ...

The U.K.-based biotech is set to enter mid-stage studies for its depression drug this year, while two other GABAA modulators ...

Biotech Beyond Borders report provides a sobering snapshot of the industry’s financial health, with more and more companies ...

Jefferies analysts said on Tuesday that Ventyx could leverage its mid-stage data for VTX3232 to position the oral drug ...

In combination with Eli Lilly’s tirzepatide, marketed as Zepbound for obesity, Scholar Rock’s monolonal antibody helped ...

AstraZeneca, Pfizer and more are leveraging the computational power of AI to better design trials, predict the potential ...